Articles:

George H. Acheson and Sidney Udenfriend

FOREWORD
Pharmacol Rev 1966 18: 3-4.  

M. Vogt

SIR JOHN GADDUM
Pharmacol Rev 1966 18: 5. [PDF]  

Arvid Carlsson

NILS-ÅKE HILLARP
Pharmacol Rev 1966 18: 5-6. [PDF]  

G. A. H. Buttle

ROSEMARY CASS
Pharmacol Rev 1966 18: 6-7. [PDF]  

U. S. von Euler

TWENTY YEARS OF NORADRENALINE
Pharmacol Rev 1966 18: 29-38. [PDF]  

H. Blaschko

A. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 39-41. [PDF]  

Sidney Udenfriend

B. TYROSINE HYDROXYLASE
Pharmacol Rev 1966 18: 43-51. [PDF]  

Theodore L. Sourkes

C. DOPA DECARBOXYLASE: SUBSTRATES, COENZYME, INHIBITORS
Pharmacol Rev 1966 18: 53-60. [PDF]  

Seymour Kaufman

D. COENZYMES AND HYDROXYLASES: ASCORBATE AND DOPAMINE--HYDROXYLASE; TETRAHYDROPTERIDINES AND PHENYLALANINE AND TYROSINE HYDROXYLASES
Pharmacol Rev 1966 18: 61-69. [PDF]  

Osamu Hayaishi

E. ENZYMIC STUDIES ON THE MECHANISM OF DOUBLE HYDROXYLATION
Pharmacol Rev 1966 18: 71-75. [PDF]  

M. Goldstein

F. INHIBITION OF NOREPINEPHRINE BIOSYNTHESIS AT THE DOPAMINE--HYDROXYLATION STAGE
Pharmacol Rev 1966 18: 77-82. [PDF]  

N. Kirshner

G. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 83-84. [PDF]  

P. Holtz

H. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 85-88. [PDF]  

Constantin E. Sekeris and Peter Karlson

I. BIOSYNTHESIS OF CATECHOLAMINES IN INSECTS
Pharmacol Rev 1966 18: 89-94. [PDF]  

Julius Axelrod

J. METHYLATION REACTIONS IN THE FORMATION AND METABOLISM OF CATECHOLAMINES AND OTHER BIOGENIC AMINES
Pharmacol Rev 1966 18: 95-113. [PDF]  

V. Z. Gorkin

K. MONOAMINE OXIDASES
Pharmacol Rev 1966 18: 115-120. [PDF]  

A. Pletscher

L. MONOAMINE OXIDASE INHIBITORS
Pharmacol Rev 1966 18: 121-129. [Abstract] [PDF]  

B. Belleau

M. STERIC EFFECTS IN CATECHOLAMINE INTERACTIONS WITH ENZYMES AND RECEPTORS
Pharmacol Rev 1966 18: 131-140. [PDF]  

E. A. Zeller

N. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 141-143. [PDF]  

S. Nara and K. T. Yasunobu

SOME RECENT ADVANCES IN THE PURIFICATION OF MITOCHONDRIAL MONOAMINE OXIDASE
Pharmacol Rev 1966 18: 144. [PDF]  

Earl W. Sutherland and G. Alan Robison

A. THE ROLE OF CYCLIC-3',5'-AMP IN RESPONSES TO CATECHOLAMINES AND OTHER HORMONES
Pharmacol Rev 1966 18: 145-161. [PDF]  

Edwin G. Krebs, Robert J. DeLange, Robert G. Kemp, and W. Dixon Riley

B. ACTIVATION OF SKELETAL MUSCLE PHOSPHORYLASE
Pharmacol Rev 1966 18: 163-171. [Abstract] [PDF]  

Tag E. Mansour

C. FACTORS INFLUENCING ACTIVATION OF PHOSPHOFRUCTOKINASE
Pharmacol Rev 1966 18: 173-179. [PDF]  

J. H. Exton and C. R. Park

D. THE STIMULATION OF GLUCONEOGENESIS FROM LACTATE BY EPINEPHRINE, GLUCAGON, AND CYCLIC 3',5'-ADENYLATE IN THE PERFUSED RAT LIVER
Pharmacol Rev 1966 18: 181-188. [Abstract] [PDF]  

Ernst Helmreich and Carl F. Cori

E. THE ACTIVATION OF GLYCOLYSIS IN FROG SARTORIUS MUSCLE BY EPINEPHRINE
Pharmacol Rev 1966 18: 189-196. [Abstract] [PDF]  

Niels Haugaard and Marilyn E. Hess

F. THE INFLUENCE OF CATECHOLAMINES ON HEART FUNCTION AND PHOSPHORYLASE ACTIVITY
Pharmacol Rev 1966 18: 197-203. [PDF]  

John R. Williamson

G. KINETIC STUDIES OF EPINEPHRINE EFFECTS IN THE PERFUSED RAT HEART
Pharmacol Rev 1966 18: 205-210. [Abstract] [PDF]  

E. Bueding

H. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 211-213. [PDF]  

M. Vaughan

I. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 215-216. [PDF]  

Daniel Steinberg

J. CATECHOLAMINE STIMULATION OF FAT MOBILIZATION AND ITS METABOLIC CONSEQUENCES
Pharmacol Rev 1966 18: 217-235. [Abstract] [PDF]  

R. W. Butcher

K. CYCLIC 3',5'-AMP AND THE LIPOLYTIC EFFECTS OF HORMONES ON ADIPOSE TISSUE
Pharmacol Rev 1966 18: 237-241. [PDF]  

L. A. Carlson

L. BLOOD AND TISSUE CHANGES INDUCED BY NOREPINEPHRINE-STIMULATED MOBILIZATION OF FREE FATTY ACIDS
Pharmacol Rev 1966 18: 242. [PDF]  

S. Garattini and A. Bizzi

M. EFFECT OF DRUGS ON MOBILIZATION OF FREE FATTY ACID
Pharmacol Rev 1966 18: 243-251. [PDF]  

T. Brody

N. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 253. [PDF]  

Lennart Lundholm, Ella Mohme-Lundholm, and Nils Svedmyr

O. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 255-272. [PDF]  

B. B. Brodie, J. I. Davies, S. Hynie, G. Krishna, and B. Weiss

P. INTERRELATIONSHIPS OF CATECHOLAMINES WITH OTHER ENDOCRINE SYSTEMS
Pharmacol Rev 1966 18: 273-289. [Abstract] [PDF]  

Loren D. Carlson

Q. THE ROLE OF CATECHOLAMINES IN COLD ADAPTATION
Pharmacol Rev 1966 18: 291-301. [PDF]  

Alan Goldfien

R. EFFECTS OF GLUCOSE DEPRIVATION ON THE SYMPATHETIC OUTFLOW TO THE ADRENAL MEDULLA AND ADIPOSE TISSUE
Pharmacol Rev 1966 18: 303-311. [PDF]  

Z. M. Bacq

S. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 313-314. [PDF]  

Marthe Vogt

A. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 315-316. [PDF]  

J. R. Vane

B. THE ESTIMATION OF CATECHOLAMINES BY BIOLOGICAL ASSAY
Pharmacol Rev 1966 18: 317-324. [Abstract] [PDF]  

Jan Häggendal

C. NEWER DEVELOPMENTS IN CATECHOLAMINE ASSAY
Pharmacol Rev 1966 18: 325-329. [PDF]  

H. Weil-Malherbe and Elizabeth R. B. Smith

D. THE ESTIMATION OF METANEPHRINE, NORMETANEPHRINE, AND 3,4-DIHYDROXYMANDELIC ACID IN URINE
Pharmacol Rev 1966 18: 331-341. [PDF]  

M. Sandler and C. R. J. Ruthven

E. THE MEASUREMENT OF 4-HYDROXY-3-METHOXYMANDELIC ACID AND HOMOVANILLIC ACID
Pharmacol Rev 1966 18: 343-351. [PDF]  

Ch. Owman

F. METHODOLOGY OF FLUORESCENCE MICROSCOPY OF CATECHOLAMINES
Pharmacol Rev 1966 18: 351.  

Olavi ErÄnkö

G. DEMONSTRATION OF CATECHOLAMINES AND CHOLINESTERASES IN THE SAME SECTION
Pharmacol Rev 1966 18: 353-358. [PDF]  

G. B. Koelle

H. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 359-364. [PDF]  

U. S. Von Euler

A. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 365-367. [PDF]  

A. Bertler, B. Falck, Ch. Owman, and E. Rosengrenn

B. THE LOCALIZATION OF MONOAMINERGIC BLOOD-BRAIN BARRIER MECHANISMS
Pharmacol Rev 1966 18: 369-385. [Abstract] [PDF]  

Mary A. Grillo

C. ELECTRON MICROSCOPY OF SYMPATHETIC TISSUES
Pharmacol Rev 1966 18: 387-399. [PDF]  

V. P. Whittaker

D. CATECHOLAMINE STORAGE PARTICLES IN THE CENTRAL NERVOUS SYSTEM
Pharmacol Rev 1966 18: 401-412. [PDF]  

Eduardo De Robertis

E. ADRENERGIC ENDINGS AND VESICLES ISOLATED FROM BRAIN
Pharmacol Rev 1966 18: 413-424. [PDF]  

Lennart Stjärne

F. STORAGE PARTICLES IN NORADRENERGIC TISSUES
Pharmacol Rev 1966 18: 425-432. [PDF]  

Hans-Joachim Schümann

G. MEDULLARY PARTICLES
Pharmacol Rev 1966 18: 433-438. [Abstract] [PDF]  

Lincoln T. Potter

H. STORAGE OF NOREPINEPHRINE IN SYMPATHETIC NERVES
Pharmacol Rev 1966 18: 439-451. [PDF]  

P. Banks and H. Blaschko

I. CHROMAFFIN TISSUE
Pharmacol Rev 1966 18: 453-456. [PDF]  

E. W. Maynert

J. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 457-458. [PDF]  

J. H. Burn

A. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 459-470. [PDF]  

W. W. Douglas

B. THE MECHANISM OF RELEASE OF CATECHOLAMINES FROM THE ADRENAL MEDULLA
Pharmacol Rev 1966 18: 471-480. [PDF]  

G. Burnstock and Mollie E. Holman

C. JUNCTION POTENTIALS AT ADRENERGIC SYNAPSES
Pharmacol Rev 1966 18: 481-493. [Abstract] [PDF]  

H. O. Schild

D. CALCIUM AND THE RELAXANT EFFECT OF ISOPROTERENOL IN THE DEPOLARIZED RAT UTERUS
Pharmacol Rev 1966 18: 495-501. [Abstract] [PDF]  

Neil C. Moran

E. PHARMACOLOGICAL CHARACTERIZATION OF ADRENERGIC RECEPTORS
Pharmacol Rev 1966 18: 503-512. [PDF]  

Irwin J. Kopin

F. BIOCHEMICAL ASPECTS OF RELEASE OF NOREPINEPHRINE AND OTHER AMINES FROM SYMPATHETIC NERVE ENDINGS
Pharmacol Rev 1966 18: 513-523. [Abstract] [PDF]  

Elwood Titus and Hans J. Dengler

G. THE MECHANISM OF UPTAKE OF NOREPINEPHRINE
Pharmacol Rev 1966 18: 525-535. [PDF]  

J. S. Gillespie

H. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 537-540. [PDF]  

Arvid Carlsson

A. PHARMACOLOGICAL DEPLETION OF CATECHOLAMINE STORES
Pharmacol Rev 1966 18: 541-549. [PDF]  

E. Muscholl

B. INDIRECTLY ACTING SYMPATHOMIMETIC AMINES
Pharmacol Rev 1966 18: 551-559. [PDF]  

P. A. Shore

C. THE MECHANISM OF NOREPINEPHRINE DEPLETION BY RESERPINE, METARAMINOL AND RELATED AGENTS. THE ROLE OF MONOAMINE OXIDASE
Pharmacol Rev 1966 18: 561-568. [PDF]  

Clement A. Stone and Curt C. Porter

D. METHYLDOPA AND ADRENERGIC NERVE FUNCTION
Pharmacol Rev 1966 18: 569-575. [PDF]  

E. Costa, D. J. Boullin, W. Hammer, W. Vogel, and B. B. Brodie

E. INTERACTIONS OF DRUGS WITH ADRENERGIC NEURONS
Pharmacol Rev 1966 18: 577-597. [Abstract] [PDF]  

Sydney Spector

F. INHIBITORS OF ENDOGENOUS CATECHOLAMINE BIOSYNTHESIS
Pharmacol Rev 1966 18: 599-609. [Abstract] [PDF]  

Theodore Cooper

G. SURGICAL SYMPATHECTOMY AND ADRENERGIC FUNCTION
Pharmacol Rev 1966 18: 611-618. [PDF]  

Rita Levi-Montalcini and Pietro U. Angeletti

H. IMMUNOSYMPATHECTOMY
Pharmacol Rev 1966 18: 619-628. [PDF]  

U. Thendelenburg

I. MECHANISMS OF SUPERSENSITIVITY AND SUBSENSITIVITY TO SYMPATHOMIMETIC AMINES
Pharmacol Rev 1966 18: 629-640. [PDF]  

R. F. Furchgott

J. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 641-644. [PDF]  

Wilfried von Studnitz

A. CHEMISTRY AND PHARMACOLOGY OF CATECHOLAMINE-SECRETING TUMORS
Pharmacol Rev 1966 18: 645-650. [PDF]  

J. Richard Crout

B. PHEOCHROMOCYTOMA
Pharmacol Rev 1966 18: 651-657. [PDF]  

Hans Käser

C. CATECHOLAMINE-PRODUCING NEURAL TUMORS OTHER THAN PHEOCHROMOCYTOMA
Pharmacol Rev 1966 18: 659-665. [PDF]  

W. S. Peart

D. CATECHOLAMINES AND HYPERTENSION
Pharmacol Rev 1966 18: 667-672. [PDF]  

Albert Sjoerdsma

E. CATECHOLAMINE-DRUG INTERACTIONS IN MAN
Pharmacol Rev 1966 18: 673-683. [Abstract] [PDF]  

Charles A. Chidsey and Eugene Braunwald

F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE
Pharmacol Rev 1966 18: 685-700. [Abstract] [PDF]  

A. C. Dornhorst

G. ADRENERGIC BLOCKADE IN CARDIOVASCULAR DISEASE
Pharmacol Rev 1966 18: 701-703. [PDF]  

B. Nikodijevi, E. Glava, and M. Polenakovi

H. CARDIOVASCULAR EFFECTS OF MONOAMINE OXIDASE INHIBITORS
Pharmacol Rev 1966 18: 705. [PDF]  

S. E. Gitlow

I. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 707-711. [PDF]  

W. Feldberg

A. INTRODUCTORY REMARKS
Pharmacol Rev 1966 18: 713-716. [PDF]  

G. C. Salmoiraghi

B. CENTRAL ADRENERGIC SYNAPSES
Pharmacol Rev 1966 18: 717-726. [Abstract] [PDF]  

N.-Å. Hillarp, Kjell Fuxe, and Annica Dahlström

C. DEMONSTRATION AND MAPPING OF CENTRAL NEURONS CONTAINING DOPAMINE, NORADRENALINE, AND 5-HYDROXYTRYPTAMINE AND THEIR REACTIONS TO PSYCHOPHARMACA
Pharmacol Rev 1966 18: 727-741. [PDF]  

Karl-Axel Norberg and Folke Sjöqvist

D. NEW POSSIBILITIES FOR ADRENERGIC MODULATION OF GANGLIONIC TRANSMISSION
Pharmacol Rev 1966 18: 743-751. [PDF]  

E. Marley

E. BEHAVIOURAL AND ELECTROPHYSIOLOGICAL EFFECTS OF CATECHOLAMINES
Pharmacol Rev 1966 18: 753-768. [PDF]  

Åke Bertler and Evald Rosengren

F. POSSIBLE ROLE OF BRAIN DOPAMINE
Pharmacol Rev 1966 18: 769-773. [PDF]  

J. Glowinski and J. Axelrod

G. EFFECTS OF DRUGS ON THE DISPOSITION OF H³-NOREPINEPHRINE IN THE RAT BRAIN
Pharmacol Rev 1966 18: 775-785. [PDF]  

Seymour S. Kety

H. CATECHOLAMINES IN NEUROPSYCHIATRIC STATES
Pharmacol Rev 1966 18: 787-798. [PDF]  

V. Varagi and M. Krsti

I. ADRENERGIC ACTIVATION BY ANTICHOLINESTERASES
Pharmacol Rev 1966 18: 799-800. [PDF]  

M. Nickerson

J. SUMMARY OF DISCUSSION AND COMMENTARY
Pharmacol Rev 1966 18: 801-803. [PDF]  

ELIZABETH C. MILLER and JAMES A. MILLERE

MECHANISMS OF CHEMICAL CARCINOGENESIS: NATURE OF PROXIMATE CARCINOGENS AND INTERACTIONS WITH MACROMOLECULES
Pharmacol Rev 1966 18: 805-838. [PDF]  

ROBERT L. VOLLE

MODIFICATION BY DRUGS OF SYNAPTIC MECHANISMS IN AUTONOMIC GANGLIA
Pharmacol Rev 1966 18: 839-869. [PDF]  

HOWARD J. SAZ and ERNEST BUEDING

RELATIONSHIPS BETWEEN ANTHELMINTIC EFFECTS AND BIOCHEMICAL AND PHYSIOLOGICAL MECHANISMS
Pharmacol Rev 1966 18: 871-894. [Abstract] [PDF]  

J. J. BRAND and W. L. M. PERRY

DRUGS USED IN MOTION SICKNESS: A CRITICAL REVIEW OF THE METHODS AVAILABLE FOR THE STUDY OF DRUGS OF POTENTIAL VALUE IN ITS TREATMENT AND OF THE INFORMATION WHICH HAS BEEN DERIVED BY THESE METHODS
Pharmacol Rev 1966 18: 895-924. [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.